( July 29, 2026, 1:58 PM EDT) -- NEW HAVEN, Conn. — A Connecticut federal judge ruled that Novo Nordisk Inc. failed to show that testimony from a warnings expert retained by a hospital system that was sued in a class action brought by patients who may have been exposed to blood-borne illnesses was inadmissible under Federal Rule of Evidence 702....